Yuan, Haixia
Cao, Yingying
Yu, Zhenjun
Huang, Yue
Liu, Fang
Gao, Yanying
Qiu, Shaotian
Han, Tao
Funding for this research was provided by:
the National 13th 5-Year Plan for Hepatitis Research (No.2017ZX10203201-007)
Article History
Received: 8 November 2022
Accepted: 12 September 2023
First Online: 19 September 2023
Declarations
:
: This retrospective study was approved by the Ethics Committee of Tianjin Third Central Hospital and conducted according to the principles of the Declaration of Helsinki (approved No. of ethic committee: SZX-IRB-SOP-016(F)-002-01). This trial was registered in the Chinese clinical trials registry: ChiCTR1900021539. We obtained written informed consent from all patients or their legal guardian.
: Not applicable.
: The authors have no conflict of interests related to this publication.